Opioid-Induced Constipation: The Science, Patient Burden, and a Prescription Treatment Approach

Sponsored by AstraZeneca and Daiichi Sankyo

This activity is not certified for credit.

Date
Thursday, September 6

Start Time
8:30a

End Time
9:30a

Room
Castellana Ballroom
Level 3

Program Description

The program objective is to gain in-depth knowledge of MOVANTIK, the first once-daily, oral therapy in its class specifically designed for the treatment of OIC in adult patients with chronic non-cancer pain.

Faculty
Gerard DeGregoris III, MD

Contact Name
Linda Corsini

Contact Phone
(888) 595-7737

Contact email
lcorsini@ahmdirect.com

Share:

Related Content